This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

JetBlue Adds Business-Class Cabin: Ahead of the Ticker

NEW YORK ( TheStreet) -- All-coach airline JetBlue Airways (JBLU - Get Report) announced it is adding a business-class cabin that will include 16 lie-flat seats on flights between New York and Los Angeles and San Francisco.

The 16 premium seats will include air cushions with adjustable firmness and massage capabilities, a 15-inch television and a "wake-me-for-service" flight-attendant indicator. They will measure 6 feet, 8 inches when reclined into full, lie-flat position. Four of the 16 seats will have doors and will be dubbed "private suites." JetBlue said 11 of its new Airbus A321 planes will feature the seats in the second quarter of 2014. Planes that include the new seats will accommodate 143 passengers in coach.

JetBlue hasn't yet announced the price of the new premium seats.

Competitors United Airlines (UAL - Get Report), American Airlines and Delta Air Lines (DAL - Get Report) have all been implementing seats that can fully recline on their transcontinental flights.






Billionaire investor Carl Icahn increased his stake in Dell (DELL - Get Report) as a shareholder vote over control of the company approaches.

Icahn disclosed in a regulatory filing late Monday that he purchased an additional 4 million shares in Dell on Thursday, bringing his stake in the company to 8.9% from 8.7%. Icahn purchased the shares on the same day he filed a suit to block a delay in a shareholder vote over control of the company.

Founder Michael Dell and investment firm Silver Lake Partners boosted their buyout bid for the company just one day later. Their bid is currently $13.75 a share, with shareholders receiving a special dividend of 13 cents share. A shareholder vote on the offer is scheduled for Sept. 12.

Icahn has bid $15.50 a share.






Drugstore chain CVS Caremark (CVS - Get Report) reported a 16% rise in second-quarter profit that beat Wall Street expectations, driven by new generic drugs, which helped to boost operating profit in pharmacy units.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG
DELL $0.00 0.00%
DAL $42.53 1.62%
CVS $103.48 0.61%
JBLU $20.18 3.20%
UAL $53.70 3.43%

Markets

DOW 18,162.99 +121.45 0.67%
S&P 500 2,123.48 +19.28 0.92%
NASDAQ 5,106.5930 +73.8420 1.47%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs